Poor prognostic tumours with increasing IGFBP-3 expression may relate to recent evidence in vitro in which the pro-apoptotic action of IGFBP-3 is reversed by the extracellular matrix protein fibronectin[B27,28]. The gene discussed is IGFBP3; the disease is neoplasm.